Bridger Management LLC Takes $4.66 Million Position in HealthEquity, Inc. $HQY

Bridger Management LLC bought a new position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 51,616 shares of the company's stock, valued at approximately $4,662,000. HealthEquity comprises approximately 3.1% of Bridger Management LLC's investment portfolio, making the stock its 14th biggest position. Bridger Management LLC owned 0.06% of HealthEquity at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in HQY. Fifth Third Wealth Advisors LLC raised its stake in HealthEquity by 4.2% during the 1st quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company's stock valued at $240,000 after buying an additional 116 shares during the last quarter. Truist Financial Corp boosted its stake in shares of HealthEquity by 4.9% in the 4th quarter. Truist Financial Corp now owns 2,537 shares of the company's stock worth $232,000 after buying an additional 119 shares during the last quarter. Fiduciary Trust Co grew its holdings in shares of HealthEquity by 3.4% in the third quarter. Fiduciary Trust Co now owns 3,669 shares of the company's stock worth $348,000 after acquiring an additional 120 shares during the period. Larson Financial Group LLC grew its holdings in shares of HealthEquity by 24.4% in the third quarter. Larson Financial Group LLC now owns 628 shares of the company's stock worth $60,000 after acquiring an additional 123 shares during the period. Finally, Merit Financial Group LLC increased its position in HealthEquity by 8.9% during the third quarter. Merit Financial Group LLC now owns 2,112 shares of the company's stock valued at $200,000 after acquiring an additional 172 shares during the last quarter. Institutional investors own 99.55% of the company's stock.

HealthEquity News Roundup

Here are the key news stories impacting HealthEquity this week:

• Positive Sentiment: HealthEquity exceeded expectations with adjusted earnings of $1.24 per share versus the $1.19 consensus, while revenue reached $350.7 million, slightly above estimates. Revenue increased 95.5% year over year. HealthEquity Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Profitability improved, with net income rising 10% to $65.6 million and net margin expanding to 19% from 18%. Adjusted EBITDA grew 11% to $167 million, while its margin increased to 48% from 46%. HealthEquity Second-Quarter Financial Results
• Positive Sentiment: Management raised fiscal 2027 adjusted EPS guidance to $4.66–$4.73, above the $4.56 analyst consensus. Record HSA assets of $37.9 billion provide additional support for the company’s long-term growth outlook. HealthEquity Raises Fiscal 2027 Guidance
• Positive Sentiment: BTIG Research reaffirmed its “buy” rating and raised its price target to $115. Another analysis indicated that HQY could be approximately 19% undervalued after the guidance increase, reinforcing the bullish interpretation of the earnings update. BTIG Research Rating HealthEquity Could Be Undervalued
• Neutral Sentiment: Fiscal 2027 revenue guidance of approximately $1.4 billion was broadly in line with expectations, so the guidance improvement was driven mainly by stronger anticipated earnings and margins.
• Negative Sentiment: Director Adrian T. Dillon sold 7,632 shares valued at approximately $798,000, reducing his position by 10.9%. The sale was executed under a pre-arranged Rule 10b5-1 plan, which reduces its negative signaling value but could still attract investor attention. HealthEquity Director Stock Sale
• Negative Sentiment: HQY trades at a premium valuation of roughly 35 times earnings. After the recent advance toward its 52-week high, some investors may lock in gains, potentially tempering the stock’s reaction to otherwise favorable fundamentals.

Analysts Set New Price Targets

HQY has been the topic of a number of recent research reports. BTIG Research reissued a "buy" rating and issued a $115.00 target price on shares of HealthEquity in a report on Friday. Weiss Ratings raised shares of HealthEquity from a "hold (c)" rating to a "hold (c+)" rating in a research report on Friday, June 5th. Telsey Advisory Group set a $111.00 price objective on shares of HealthEquity in a research note on Friday. Wall Street Zen raised shares of HealthEquity from a "hold" rating to a "buy" rating in a report on Saturday, August 22nd. Finally, Citigroup restated a "market outperform" rating on shares of HealthEquity in a research report on Friday. Eleven equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $110.93.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 2,354 shares of the stock in a transaction on Friday, July 10th. The stock was sold at an average price of $95.00, for a total value of $223,630.00. Following the completion of the sale, the executive vice president owned 52,244 shares in the company, valued at approximately $4,963,180. This represents a 4.31% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Adrian T. Dillon sold 7,632 shares of the stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the completion of the sale, the director owned 62,395 shares of the company's stock, valued at $6,527,140.95. The trade was a 10.90% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 12,456 shares of company stock worth $1,256,664 over the last 90 days. Insiders own 1.60% of the company's stock.

HealthEquity Trading Up 3.2%

HealthEquity stock opened at $96.37 on Friday. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $107.62. The firm has a market capitalization of $8.06 billion, a price-to-earnings ratio of 34.79, a P/E/G ratio of 1.57 and a beta of 0.21. The firm has a 50 day moving average of $98.16 and a 200 day moving average of $87.87. The company has a current ratio of 2.99, a quick ratio of 3.44 and a debt-to-equity ratio of 0.47.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Thursday, August 27th. The company reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.05. The business had revenue of $350.73 million for the quarter, compared to the consensus estimate of $349.22 million. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The business's quarterly revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, research analysts predict that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

HealthEquity Company Profile

HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source